SCHEMBL245937

SCHEMBL245937

C1=Cc2nc1c(-c1ccncc1)c1ccc([nH]1)c(-c1ccncc1)c1nc(c(-c3ccncc3)c3ccc([nH]3)c2-c2ccncc2)C=C1

nearest known ligand 0.78

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ TOP1 P11387 4/20 0.78
▸ TERT O14746 4/20 0.59
▸ CYCS P99999 3/20 0.56
▸ ENPP2 Q13822 1/20 0.54
▸ ABCG2 Q9UNQ0 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29961137 1.00 TOP1 (0.78) TOP1TERTCYCSENPP2ABCG2
SCHEMBL31313985 0.98 TOP1 (0.76) TOP1TERTCYCSENPP2ABCG2
SCHEMBL31315103 0.98 TOP1 (0.76) TOP1TERTCYCSENPP2ABCG2
SCHEMBL31313917 0.98 TOP1 (0.76) TOP1TERTCYCSENPP2ABCG2
SCHEMBL2423633 0.98 TOP1 (0.76) TOP1TERTCYCSENPP2ABCG2
Hydrochloric Acid SCHEMBL2101556 0.98 TOP1 (0.76) TOP1TERTCYCSENPP2ABCG2
SCHEMBL30915394 0.98 TOP1 (0.76) TOP1TERTCYCSENPP2ABCG2
SCHEMBL600975 0.98 TOP1 (0.76) TOP1TERTCYCSENPP2ABCG2
SCHEMBL31313616 0.98 TOP1 (0.76) TOP1TERTCYCSENPP2ABCG2
Magnesium SCHEMBL31258521 0.98 TOP1 (0.76) TOP1TERTCYCSENPP2ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 576 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12565426-B2 Photothermal catalytic method for production of hydrogen peroxide without sacrificial reagents on basis of porphyrin-based supermolecule JIANGNAN UNIVERSITY (CN) 2026-03-03 — — US claimed
CN-120137179-A Method for preparing high refractive index polymer material 李科 2025-06-13 — — CN claimed
CN-119818661-A Tumor vaccine containing heterogeneous fusion membrane and preparation method and application thereof 四川大学华西医院 2025-04-15 — — CN claimed
CN-119823403-A Preparation method and application of dual-ligand MOF photocatalyst 中国石油大学(华东) 2025-04-15 — — CN claimed
CN-119433582-A Preparation method and application of nitrogen-doped porous carbon supported metal catalyst 六盘水师范学院 2025-02-14 — — CN claimed
US-20240366545-A1 ANTIBACTERIAL PORPHYRIN NANOPARTICLES AND METHODS FOR MAKING AND USING THE SAME NATIONAL INSTITUTES OF HEALTH 2024-11-07 — — US claimed
CN-116020418-B Modified metal organic adsorbent for precious metal recovery and preparation method and application thereof 清华大学 2024-10-29 — — CN claimed
EP-3206987-B2 NANOPARTICLES FOR PHOTODYNAMIC THERAPY, X-RAY INDUCED PHOTODYNAMIC THERAPY, RADIOTHERAPY, CHEMOTHERAPY, IMMUNOTHERAPY, AND ANY COMBINATION THEREOF UNIV CHICAGO (US) 2024-07-24 — — EP claimed
CN-114602437-B Adsorbent for obtaining high-octane component from C6 hydrocarbon and preparation method thereof 南昌大学 2024-07-05 — — CN claimed
CN-118267535-A Artificial biological composite material with active oxygen scavenging effect and preparation and application thereof 四川大学 2024-07-02 — — CN claimed
US-4987226-A CATALYSTS FOR EPOXIDATION OF OLEFINS WITH HYDROGEN PEROXIDE DEGUSSA AKTIENGESELLSCHAFT (DE) 1991-01-22 — — US claimed
US-4973718-A RHENIUM PROPHYRIN CATALYST DEGUSSA AKTIENGESELLSCHAFT (DE) 1990-11-27 — — US claimed
EP-0308791-B1 PROCESS FOR THE CATALYTIC EPOXYDATION OF OLEFINS WITH HYDROGEN PEROXIDE Degussa Aktiengesellschaft (DE) 1990-11-14 — — EP claimed
EP-0283753-B1 PROCESS FOR THE CATALYTIC EPOXIDATION OF OLEFINS WITH HYDROGEN PEROXIDE Degussa Aktiengesellschaft (DE) 1990-09-19 — — EP claimed
US-4845252-A COMPLEX TUNGSTEN CATALYST DEGUSSA AKTIENGESELLSCHAFT (DE) 1989-07-04 — — US claimed
EP-0308790-A2 Rhenium-oxo-porphyrin complexes Degussa Aktiengesellschaft (DE) 1989-03-29 — — EP claimed
EP-0308791-A1 Process for the catalytic epoxydation of olefins with hydrogen peroxide Degussa Aktiengesellschaft (DE) 1989-03-29 — — EP claimed
EP-0283753-A1 Process for the catalytic epoxidation of olefins with hydrogen peroxide Degussa Aktiengesellschaft (DE) 1988-09-28 — — EP claimed
EP-0283754-A2 Tungsten oxo-porphyrin complexes Degussa Aktiengesellschaft (DE) 1988-09-28 — — EP claimed
EP-0222167-A2 Process for the catalytic epoxidation of olefines with hydrogen peroxide Degussa Aktiengesellschaft (DE) 1987-05-20 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12565426-B2 Photothermal catalytic method for production of hydrogen peroxide without sacrificial reagents on basis of porphyrin-based supermolecule TPO, PPOX, THPO TOP1 446/4885TERT 167/4885CYCS 282/4885
US-20240366545-A1 ANTIBACTERIAL PORPHYRIN NANOPARTICLES AND METHODS FOR MAKING AND USING THE SAME GPX1, NOS1, NOS2 TOP1 456/4885TERT 2088/4885CYCS 994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback